Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
08:30am, Wednesday, 18'th Oct 2023
MELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
09:00am, Friday, 06'th Oct 2023
ORLANDO, FL / ACCESSWIRE / October 6, 2023 / RedChip Companies will air interviews with Knightscope, Inc. (NASDAQ:KSCP), Soligenix, Inc. (Nasdaq:SNGX), and Genetic Technologies Limited (ASX:GTG)(NASDA
GTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital Network
09:00am, Wednesday, 27'th Sep 2023
MELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness
ORLANDO, FL / ACCESSWIRE / September 15, 2023 / RedChip Companies will air interviews with Aridis Pharmaceuticals, Inc. (OTC:ARDS), Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE), and American Re
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
08:30am, Monday, 11'th Sep 2023
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
06:15am, Saturday, 02'nd Sep 2023
Veracyte's revenue sharply rose in the second quarter. The company is moving toward profitability.
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
10:00am, Friday, 01'st Sep 2023
MELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in he
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
09:00am, Friday, 01'st Sep 2023
ORLANDO, FL / ACCESSWIRE / September 1, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited (Nasdaq:GENE) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) on The RedChip Money R
Annual Results – Momentum Building on our Commercial Plans
08:45am, Wednesday, 30'th Aug 2023
MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in hea
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced the successful completion of an employer-sponsored heart disease fair in Kansas, United States.
Genetic Technologies Limited (GENE) Q4 2023 Earnings Call Transcript
12:11am, Wednesday, 09'th Aug 2023
Genetic Technologies Limited (NASDAQ:GENE ) Q4 2023 Earnings Conference Call August 8, 2023 7:15 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer
Genetic Technologies Limited (GENE) Q3 2023 Earnings Call Transcript
11:45pm, Wednesday, 03'rd May 2023
Genetic Technologies Limited (NASDAQ:GENE ) Q3 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Ton
Best Penny Stocks To Buy: 5 To Watch With Big News This Week
10:19am, Monday, 06'th Feb 2023
Penny stocks to watch with big news this week. The post Best Penny Stocks To Buy: 5 To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Genetic Technologies Announces $5 Million Registered Direct Offering
01:35pm, Friday, 03'rd Feb 2023 GlobeNewswire Inc.
MELBOURNE, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-dri
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
01:00pm, Friday, 03'rd Feb 2023 GlobeNewswire Inc.
MELBOURNE, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness an
